196 related articles for article (PubMed ID: 37452322)
21. Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway.
Huang G; Chen S; Washio J; Paka Lubamba G; Takahashi N; Li C
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768316
[TBL] [Abstract][Full Text] [Related]
22. The expression and role of tubulin polymerization-promoting protein 3 in oral squamous cell carcinoma.
Xiao T; Lin F; Zhou J; Tang Z
Arch Oral Biol; 2022 Nov; 143():105519. PubMed ID: 36058091
[TBL] [Abstract][Full Text] [Related]
23. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
Lin X; Ding JM; Zheng XZ; Chen JG
Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
[TBL] [Abstract][Full Text] [Related]
24. Genetic Cross-Talk between Oral Squamous Cell Carcinoma and Type 2 Diabetes: The Potential Role of Immunity.
Fan Y; Zhang J; Shi J; Chen L; Long J; Zhang S; Liu S
Dis Markers; 2022; 2022():6389906. PubMed ID: 35634436
[TBL] [Abstract][Full Text] [Related]
25. Identification of potential druggable targets of cell cycle with small-molecule inhibitors in oral squamous cell carcinoma.
Zhou X; Jin W; Chen Y; Zhu L; Mo A; Xie Q
Pharmacogenet Genomics; 2022 Jun; 32(4):125-137. PubMed ID: 34954767
[TBL] [Abstract][Full Text] [Related]
26. NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.
Arora R; Haynes L; Kumar M; McNeil R; Ashkani J; Nakoneshny SC; Matthews TW; Chandarana S; Hart RD; Jones SJM; Dort JC; Itani D; Chanda A; Bose P
Cancer Gene Ther; 2023 May; 30(5):752-765. PubMed ID: 36635327
[TBL] [Abstract][Full Text] [Related]
27. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C
Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734
[TBL] [Abstract][Full Text] [Related]
28. Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma.
Zhang W; Jing Y; Wang S; Wu Y; Sun Y; Zhuang J; Huang X; Chen S; Zhang X; Song Y; Hu Q; Ni Y
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291696
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of miRNA-196a and miRNA-196b correlates with Bryne's prognostic score in oral squamous cell carcinoma.
Singh K; Urs AB; Koner BC; Augustine J; Shrivastava R; Narayan B
Pathol Res Pract; 2024 Jan; 253():154954. PubMed ID: 38039741
[TBL] [Abstract][Full Text] [Related]
30. A prognostic model for oral squamous cell carcinoma using 7 genes related to tumor mutational burden.
Wu F; Du Y; Hou X; Cheng W
BMC Oral Health; 2022 Apr; 22(1):152. PubMed ID: 35488327
[TBL] [Abstract][Full Text] [Related]
31. Ubiquitination, SUMOylation, and NEDDylation related genes serve as prognostic and therapeutic biomarkers for oral squamous cell carcinoma.
Deng SZ; Wu X; Kong L; Cheng B; Dai L
J Oral Pathol Med; 2024 Feb; 53(2):114-123. PubMed ID: 38234119
[TBL] [Abstract][Full Text] [Related]
32. Implications of Human Antimicrobial Peptide Defensin Beta-1 in Clinical Oral Squamous Cell Carcinoma Patients via an Integrated Bioinformatics Approach.
Li S; Li H; Xu Y; Ning W; Hu S; Wei S; Song H; Sun J; Ziebolz D; Schmalz G; Hu X; Liu M
Comput Math Methods Med; 2022; 2022():2203615. PubMed ID: 35222682
[TBL] [Abstract][Full Text] [Related]
33. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
[TBL] [Abstract][Full Text] [Related]
34. IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma.
Wang X; Xu H; Zhou Z; Guo S; Chen R
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35129592
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/β-catenin signaling pathway.
Wang Z; Guan W; Ma Y; Zhou X; Song G; Wei J; Wang C
BMC Cancer; 2023 Jul; 23(1):668. PubMed ID: 37460940
[TBL] [Abstract][Full Text] [Related]
36. Poor Prognosis of Oral Squamous Cell Carcinoma Correlates With ITGA6.
Zhang C; Cai Q; Ke J
Int Dent J; 2023 Apr; 73(2):178-185. PubMed ID: 35820930
[TBL] [Abstract][Full Text] [Related]
37. Deregulation of hsa_circ_0001971/miR-186 and hsa_circ_0001874/miR-296 signaling pathways promotes the proliferation of oral squamous carcinoma cells by synergistically activating SHP2/PLK1 signals.
Jun W; Shaobo O; Xianhua Z; Siyu Z; Mingyang C; Xin F; Ying C; Lan L
Sci Rep; 2021 Oct; 11(1):20561. PubMed ID: 34663837
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
[TBL] [Abstract][Full Text] [Related]
40. Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).
Dong Y; Xue L; Zhang Y; Liu C; Zhang Y; Jiang N; Ma X; Chen F; Li L; Yu L; Liu X; Shao S; Guan S; Zhang J; Xiao Q; Li H; Dong A; Huang L; Shi C; Wang Y; Fu M; Lv N; Zhan Q
J Exp Clin Cancer Res; 2022 Apr; 41(1):150. PubMed ID: 35449073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
